Royal College of Nursing cuts ties with Israeli drug company
Britain’s nursing union axes Teva UK as commercial partner over links to Israel’s military and corporate track record Britain’s nursing union has cut its ties with an Israeli drug company over the firm’s links to the country’s military and track record of corporate misconduct. The Royal College of Nursing (RCN) has axed Teva UK as a commercial partner and as sponsor of a forthcoming event on…
The Royal College of Nursing (RCN) has severed its commercial partnership with an Israeli drug company, Teva UK, citing links to the country's military and a history of corporate misconduct. The RCN, which represents over 500,000 nurses in the UK, made the decision following pressure from campaign groups Nurses for Palestine and UK Healthcare Petitions to Royal Colleges (UKHPRC).
The event on migraine and headaches, scheduled for October 30, 2026, will proceed as planned without Teva UK's sponsorship. Teva UK, the UK arm of the global drug giant Teva Pharmaceuticals, expressed disappointment with the RCN's decision, arguing that healthcare had been "politicized." Pro-Palestine groups hailed the move as a "major breakthrough" for grassroots healthcare organizing and the international boycott, divestment, and sanctions movement.
Teva has faced numerous legal sanctions and fines in recent years for bribery, price-fixing, and abuse of its market position in the UK and other countries.
Written by urgent.news from Guardian Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
